BATAILLE R ET AL: "Biologic effects of anti-interleukin-6 murine monoclonal antibody in advanced multiple myeloma", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 86, no. 2, 15 July 1995 (1995-07-15), pages 685-691, XP002448659, ISSN: 0006-4971 (B1)

ZAKI M H ET AL: "CNTO 328, A monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice", INTERNATIONAL JOURNAL OF CANCER, JOHN WILEY & SONS, INC, US, vol. 111, 1 January 2004 (2004-01-01), pages 592-595, XP003012697, ISSN: 0020-7136, DOI: 10.1002/IJC.20270 (B1)

G STRASSMANN ET AL: "Evidence for the involvement of interleukin 6 in experimental cancer cachexia.", JOURNAL OF CLINICAL INVESTIGATION, vol. 89, no. 5, 1 May 1992 (1992-05-01), pages 1681-1684, XP055045903, ISSN: 0021-9738, DOI: 10.1172/JCI115767 (B1)

KAORI FUJIMOTO-OUCHI ET AL: "Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models", CANCER CHEMOTHERAPY AND PHARMACOLOGY, SPRINGER, BERLIN, DE, vol. 59, no. 6, 29 September 2006 (2006-09-29), pages 807-815, XP019490080, ISSN: 1432-0843 (B1)

KLEIN ET AL: "Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia.", BLOOD, vol. 78, no. 5, 1 September 1991 (1991-09-01), pages 1198-1204, XP055045905, ISSN: 0006-4971 (B1)

M. H. ZAKI ET AL: "Proc Am Soc Clin Oncol", 2003 ASCO ANNUAL MEETING - DEVELOPMENTAL THERAPEUTICS - CLINICAL PHARMACOLOGY AND IMMUNOTHERAPY , vol. 22, 697, 2003, XP055045899, Retrieved from the Internet: URL:http://www.asco.org/ASCOv2/Meetings/Ab stracts?&vmview=abst_detail_view&confID=23 &abstractID=100701 [retrieved on 2012-11-27] (B1)

MATSUYAMA MASASHI ET AL: "Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman's disease", INTERNAL MEDICINE, JAPANESE SOCIETY OF INTERNAL MEDICINE, TOKYO, JP; BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US, vol. 46, 1 January 2007 (2007-01-01), pages 771-774, XP002696891, ISSN: 0918-2918, DOI: 10.2169/INTERNALMEDICINE.46.6262 (B1)

STRASSMANN G ET AL: "INHIBITION OF EXPERIMENTAL CANCER CACHEXIA BY ANTI-CYTOKINE AND ANTI-CYTOKINE-RECEPTOR THERAPY", CYTOKINES AND MOLECULAR THERAPY, DUNITZ, LONDON, GB, vol. 1, no. 2, 1 January 1995 (1995-01-01) , pages 107-113, XP008043222, ISSN: 1355-6568 (B1)

SUMIE TAMURA ET AL: "Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.", CLINICAL CANCER RESEARCH, vol. 1, 1 January 1995 (1995-01-01), pages 1353-1358, XP055045909, (B1)

TRIKHA MOHIT ET AL: "Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence", CLINICAL CANCER RESEARCH, THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 9, no. 13, 1 January 2003 (2003-01-01), pages 4653-4665, XP002543280, ISSN: 1078-0432 (B1)

Thomson Reuters - Integrity: "Huamnized Anti-IL-6 monoclonal antibody - Heavy and light chains", , 16 January 2008 (2008-01-16), XP055292638, Retrieved from the Internet: URL:https://integrity.thomson-pharma.com/i ntegrity/xmlxsl/pk_prod_list.xml_prod_list _card_pr?p_id=468410 [retrieved on 2016-08-01] (B1)

US-A1- 2003 219 839 (B1)

US-A1- 2004 014 658 (B1)

US-A1- 2007 280 941 (B1)

US-A1- 2007 292 420 (B1)

US-A1- 2008 075 726 (B1)

US-B1- 6 709 660 (B1)

US-B2- 7 345 217 (B1)

US-B2- 7 431 927 (B1)

VAN ZAANEN H C T ET AL: "Chimaeric anti-interleukin 6 monoclonal antibodies in the treatment of advanced multiple myeloma: a phase I dose-escalating study", BRITISH JOURNAL OF HAEMATOLOGY, WILEY-BLACKWELL PUBLISHING LTD, GB, vol. 102, 1 January 1998 (1998-01-01), pages 783-790, XP002986057, ISSN: 0007-1048, DOI: 10.1046/J.1365-2141.1998.00835.X (B1)

VAN ZAANEN H C T ET AL: "Endogenous interleukin 6 production in multiple myeloma patients treated with himeric monoclonal anti-IL6 antibodies indicates the existence of a positive feed-back loop", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, vol. 98, no. 6, 1 September 1996 (1996-09-01), pages 1441-1448, XP008092204, ISSN: 0021-9738, DOI: 10.1172/JCI118932 (B1)

WO-A1-2004/039826 (B1)

WO-A2-2004/078938 (B1)

WO-A2-2008/065378 (B1)

WO-A2-2008/144763 (B1)

EMILLE D ET AL: "ADMINISTRATION OF AN ANTI-INTERLEUKIN-6 MONOCLONAL ANTIBODY TO PATIENTS WITH ACQUIRED IMUNODEFICIENCY SYNDROME AND LYMPHOMA: EFFECT ON LYMPHOMA GROWTH AND ON B CLINICAL SYMPTOMS", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 84, no. 8, 15 October 1994 (1994-10-15), pages 2472-2479, XP001088120, ISSN: 0006-4971 (B1)